NCT05093361

Brief Summary

The purpose of this study is to compare the effect of total hip arthroplasty and conservative treatment to hip pain, to activities of daily life and to the quality of life in patients with hip osteoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 10, 2018

Completed
2.9 years until next milestone

First Posted

Study publicly available on registry

October 26, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2023

Completed
Last Updated

March 23, 2023

Status Verified

April 1, 2022

Enrollment Period

5.4 years

First QC Date

December 10, 2018

Last Update Submit

March 22, 2023

Conditions

Keywords

Hip ArthritisTotal Hip ArthroplastyTHAConservative Treatment

Outcome Measures

Primary Outcomes (2)

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints. The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Physical functioning questions cover everyday activities such as stair use, standing up from a sitting or lying position, standing, bending, walking, getting in and out of a car, shopping, putting on or taking off socks, lying in bed, getting in or out of a bath, sitting, and heavy and light household duties. Higher scores indicate worse pain, stiffness, and functional limitations.

    From baseline to one year

  • Harris Hip Score (HHS)

    The Harris Hip Score (HHS) is a clinician-based outcome measure frequently used for the evaluation of patients following a total hip arthroplasty. Four subscales make up HHS. The first is pain, which measures pain severity (44 points); function, which is made up of daily activities and gait (47 points); the absence of deformity, which is a subscale that measures hip flexion, adduction, internal rotation, leg length discrepancy and range of motion measures.(4 points), and range of motion (5 points). The survey has 10 question items and scores range from 0-100 with higher scores representing less dysfunction and better outcomes.

    From baseline to one year

Secondary Outcomes (17)

  • The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sub Score Pain

    From baseline to one year

  • The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sub Score Stiffness

    From baseline to one year

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Sub Score Physical Function

    From baseline to one year

  • 30s Chair Stand Test

    From baseline to one year

  • 40m Fast-paced Walk Test

    From baseline to one year

  • +12 more secondary outcomes

Study Arms (2)

Operative Treatment

ACTIVE COMPARATOR

Total Hip Arthroplasty

Procedure: Total Hip Arthroplasty

Conservative Treatment

ACTIVE COMPARATOR

Physical therapy

Procedure: Physical Therapy

Interventions

Total Hip Arthroplasty for the treatment of hip arthritis.

Operative Treatment

Self-driven training according to the training plan instructed by physical therapist.

Conservative Treatment

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Hip osteoarthritis that is in X-ray pictures ≥2 in Kellgren - Lawrence classification
  • Primary osteoarthritis
  • Patients symptoms of hip osteoarthritis are so severe, that an experienced orthopedist would suggest total hip arthroplasty as a treatment

You may not qualify if:

  • Patients symptoms are so severe that total hip arthroplasty should be done within the next three months
  • ASA \> 3 (ASA physical status classification system)
  • Normal contraindications to surgery
  • Previous surgery to the same hip that has the osteoarthritis (including total hip arthroplasty, surgery for fracture, osteotomy, arthroscopy)
  • The referring orthopedist has placed the patient in line for hip arthroplasty
  • Secondary osteoarhritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kuopio University Hospital

Kuopio, Northern Savonia, 70029, Finland

Location

MeSH Terms

Interventions

Arthroplasty, Replacement, HipPhysical Therapy Modalities

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis ImplantationTherapeuticsRehabilitation

Study Officials

  • Aapo Talonpoika

    Kuopio University Hospital

    PRINCIPAL INVESTIGATOR
  • Jari Arokoski

    Kuopio University Hospital and Helsinki University Hospital

    STUDY DIRECTOR
  • Lauri Karttunen

    Kuopio University Hospital

    PRINCIPAL INVESTIGATOR
  • Hannu Luomajoki

    Zürcher Hochschule für Angewandte Wissenschaften ZHAW Departement Gesundheit, Institut für Physiotherapie

    STUDY DIRECTOR
  • Jukka Huopio

    Kuopio University Hospital

    STUDY DIRECTOR
  • Antti Jaroma

    Kuopio University Hospital

    STUDY DIRECTOR
  • Joonas Sirola

    Kuopio University Hospital

    STUDY DIRECTOR
  • Heikki Kröger

    Kuopio University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2018

First Posted

October 26, 2021

Study Start

September 1, 2017

Primary Completion

January 20, 2023

Study Completion

January 20, 2023

Last Updated

March 23, 2023

Record last verified: 2022-04

Locations